RFG
HAE icon

RFP Financial Group’s Haemonetics HAE Stock Holding History

RFP Financial Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$83 – 395
2024
Q2 		$83 Hold
1
– – ﹤0.01% 893
2024
Q1 		$85 Sell
1
-12
-92% -$942 ﹤0.01% 841
2023
Q4 		$1.11K Hold
13
– – ﹤0.01% 764
2023
Q3 		$1.17K Hold
13
– – ﹤0.01% 756
2023
Q2 		$1.11K Hold
13
– – ﹤0.01% 802
2023
Q1 		$1.08K Hold
13
– – ﹤0.01% 625
2022
Q4 		$1.02K Buy
+13
New +$1.04K ﹤0.01% 770

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

RFP Financial Group's HAE Position: Q3 2024 in Review

RFP Financial Group sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 1 share — an estimated $83 sold.

RFP Financial Group first reported a position in HAE in Q4 2022 and held it in 7 quarters. The position peaked at $1.17K in Q3 2023. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • RFP Financial Group reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 1 Haemonetics share in Q3 2024, an estimated $83.
  • RFP Financial Group first reported a position in Haemonetics in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Haemonetics position peaked at $1.17K in Q3 2023.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.